FundingWatcher
Home / Startups / By venture fund / Sofinnova Partners portfolio companies

Sofinnova Partners portfolio companies

Updated 16 Nov 2026

https://www.sofinnovapartners.com

Sofinnova Partners portfolio companies
One-time CSV
  • 35 funded companies, 26 with a website
  • Last round, amount, date, total raised and investors
  • CRM-ready CSV, 18 columns
  • Download right after payment
With founder contacts
Compiled to order
  • The full startup CSV, plus founders and executives
  • Up to 2 founders or CEOs per company, compiled to order
  • Name, job title and LinkedIn URL where found
  • Verified direct email per person
  • Startup CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

startups-investor-sofinnova-partners.csv35 rows × 18 columns
CompanyCityLast roundAmountDate
T-TherapeuticsCambridgeSeries B$133.0M2026-11-05
DISCO PharmaceuticalsCologneSeed$42.3M2025-12-11
Kainova TherapeuticsMontréalSeries B$23.5M2026-02-09
MironidGlasgowSeries B$45.9M2026-08-05
GlycoEraWädenswilSeries B$130.0M2025-05-27
BetteromicsRedwood CitySeries A$20.0M2023-10-26
Bon VivantLyonSeries A$29.4M2026-02-24
SynthaceLondonSeries C$35.0M2021-11-16

8 rows of the CSV in 5 of its 18 columns.

35
Startups
$1.6B
Total raised
5
Funded in the last 12 months
$274.1M
Raised in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Newest rounds

17 of 35
17 rows
Company What they do Sector Location Last round Amount Date Total raised Investors Employees Founded
T-Therapeutics T-Therapeutics develops T cell receptor therapies, spun off from the University of Cambridge. Biotech Cambridge, United Kingdom Series B $133.0M 2026-11-05 $224.6M F-Prime, Sofinnova Partners, Digitalis Ventures +2 51 to 100 2022
Mironid Mironid discovers drugs to treat degenerative kidney diseases, chronic inflammatory diseases, and cancer. Biotech Glasgow, United Kingdom Series B $45.9M 2026-08-05 $90.6M Scottish Enterprise, Sofinnova Partners, European Investment Fund +1 11 to 50 2014
Bon Vivant Bon Vivant uses precision fermentation to produce real dairy products accessible to everyone. Biotech Lyon, France Series A $29.4M 2026-02-24 $59.6M Kima Ventures, Picus Capital, Sofinnova Partners +1 11 to 50 2021
Kainova Therapeutics Kainova Therapeutics develops therapies that modulate GPCRs to treat immuno-oncology and inflammatory conditions. Biotech Montréal, Canada Series B $23.5M 2026-02-09 $123.6M Bpifrance, Sofinnova Partners, Andera Partners +1 11 to 50 2001
DISCO Pharmaceuticals DISCO Pharmaceuticals performs large-scale surfaceome mapping of cancer cells to find drug targets. Health care Cologne, Germany Seed $42.3M 2025-12-11 $64.0M Sofinnova Partners, M Ventures, AbbVie +1 11 to 50 2022
Qorium Qorium makes reinvented real leather materials. Biotech Maastricht, The Netherlands Series A $25.5M 2025-11-11 $28.6M Sofinnova Partners, Brightlands Venture Partners 11 to 50 2021
ENYO Pharma ENYO Pharma is a biopharmaceutical company based in Lyon, France. Biotech Lyon, France Series C $7.0M 2025-06-12 $108.8M Bpifrance, OrbiMed, Sofinnova Partners +2 11 to 50 2014
GlycoEra GlycoEra researches and produces extracellular protein degraders for treating autoimmune diseases. Biotech Wädenswil, Switzerland Series B $130.0M 2025-05-27 $179.3M Sofinnova Partners, Bristol-Myers Squibb, 5AM Ventures +1 11 to 50 2020
Noema Pharma Noema Pharma develops therapies that treat disabling symptoms of brain and nervous system conditions. Biotech Basel, Switzerland Series B $147.2M 2024-12-11 $316.5M Polaris Partners, Sofinnova Partners, Invus +2 11 to 50 2019
deepc deepc provides an AI operating system for radiology. Artificial intelligence Munich, Germany Series A $13.0M 2024-07-25 $26.0M VentureOut, Sofinnova Partners, Bertelsmann Investments +2 11 to 50 2019
EndoRon Medical EndoRon Medical develops an endovascular suture-like device for treating abdominal aortic aneurysm. Health care Kfar Saba, Israel Series A $10.0M 2024-07-09 European Innovation Council, MedTech Innovator, Sofinnova Partners 1 to 10 2019
Betteromics BetterOmics provides a SaaS platform with AI and computational tools for life sciences professionals. Artificial intelligence Redwood City, United States Series A $20.0M 2023-10-26 $20.0M Sofinnova Partners, SHAKTI, Triatomic Capital 11 to 50 2020
Sitryx Therapeutics Sitryx Therapeutics develops disease-modifying therapeutics in immuno-oncology and immuno-inflammation. Biotech Oxford, United Kingdom Series A $39.0M 2023-09-27 Sofinnova Partners, Oxford Science Enterprises, SV Health Investors +1 11 to 50 2018
Gradient Denervation Technologies Gradient Denervation Technologies develops a transvascular medical device for treating pulmonary hypertension. Biotech Paris, France Series A $15.0M 2023-09-07 MedTech Innovator, Sofinnova Partners, Thuja Capital +1 11 to 50 2019
POLYNEURON Polyneuron is a pharmaceutical company developing a new drug class for autoimmune disorders. Biotech Basel, Switzerland Series A $15.4M 2020-09-16 $45.0M New Enterprise Associates, Venture Kick, Sofinnova Partners +1 1 to 10 2014
Sensitive Object Sensitive Object develops electronic products for consumer electronics, home automation, and interactive digital advertising. Hardware Boulogne-billancourt, France Series B $6.0M 2009-12-03 Sofinnova Partners, Motorola Solutions Venture Capital 1 to 10 2003
PregLem PregLem is a Swiss biopharmaceutical company that develops and commercializes new drugs. Biotech Geneva, Switzerland Series B $32.2M 2007-12-04 $58.2M Sofinnova Partners, Sofinnova Investments, MVM Life Science Partners +1 11 to 50 2006

Table 1. Sofinnova Partners portfolio companies: the 17 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 35.

Largest rounds

Last 12 months
# Company What they do Sector Location Last round Amount Date Total raised Investors Employees Founded
1 T-Therapeutics T-Therapeutics develops T cell receptor therapies, spun off from the University of Cambridge. Biotech Cambridge, United Kingdom Series B $133.0M 2026-11-05 $224.6M F-Prime, Sofinnova Partners, Digitalis Ventures +2 51 to 100 2022
2 Mironid Mironid discovers drugs to treat degenerative kidney diseases, chronic inflammatory diseases, and cancer. Biotech Glasgow, United Kingdom Series B $45.9M 2026-08-05 $90.6M Scottish Enterprise, Sofinnova Partners, European Investment Fund +1 11 to 50 2014
3 DISCO Pharmaceuticals DISCO Pharmaceuticals performs large-scale surfaceome mapping of cancer cells to find drug targets. Health care Cologne, Germany Seed $42.3M 2025-12-11 $64.0M Sofinnova Partners, M Ventures, AbbVie +1 11 to 50 2022
4 Bon Vivant Bon Vivant uses precision fermentation to produce real dairy products accessible to everyone. Biotech Lyon, France Series A $29.4M 2026-02-24 $59.6M Kima Ventures, Picus Capital, Sofinnova Partners +1 11 to 50 2021
5 Kainova Therapeutics Kainova Therapeutics develops therapies that modulate GPCRs to treat immuno-oncology and inflammatory conditions. Biotech Montréal, Canada Series B $23.5M 2026-02-09 $123.6M Bpifrance, Sofinnova Partners, Andera Partners +1 11 to 50 2001

Table 2. Sofinnova Partners portfolio companies: the 5 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most active investors

By companies backed
#InvestorTypeLocation CompaniesShare Funded, 12 monthsLatest
1 Bpifrance Government investment office Maisons-alfort, France 4 11% 1 Kainova Therapeutics
2 Sofinnova Investments Venture capital firm Menlo Park, United States 3 9%
3 Andera Partners Private equity firm Paris, France 2 6% 1 Kainova Therapeutics
4 Forbion Capital Partners Private equity firm Naarden, The Netherlands 2 6%
5 MedTech Innovator Startup accelerator Los Angeles, United States 2 6%
6 Ventech Venture capital firm Paris, France 2 6%
7 Partners Group Private equity firm Baar, Switzerland 2 6%
8 Earlybird Venture Capital Venture capital firm Berlin, Germany 2 6%
9 University of Cambridge Enterprise University program Cambridge, United Kingdom 1 3% 1 T-Therapeutics
10 Digitalis Ventures Venture capital firm New York, United States 1 3% 1 T-Therapeutics
11 F-Prime Venture capital firm Cambridge, United States 1 3% 1 T-Therapeutics
12 Cambridge Innovation Capital Venture capital firm Cambridge, United Kingdom 1 3% 1 T-Therapeutics
13 AbbVie Corporate venture arm North Chicago, United States 1 3% 1 DISCO Pharmaceuticals
14 Panakes Partners Venture capital firm Milan, Italy 1 3% 1 DISCO Pharmaceuticals
15 M Ventures Corporate venture arm Amsterdam, The Netherlands 1 3% 1 DISCO Pharmaceuticals

Table 3. Sofinnova Partners portfolio companies: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Sectors

SectorsCompaniesShareTotal raised
Biotech 19 54% $1.4B
Health care 19 54% $1.4B
Software 15 43% $157.2M
Artificial intelligence 4 11% $64.0M
Hardware 4 11% $20.0M
Commerce 1 3%
Cybersecurity 1 3%
Fintech 1 3% $55.0M

Table 4. Sofinnova Partners portfolio companies by sector. Source: FundingWatcher. Data as of 16 November 2026.

Funding stage

Funding stageCompaniesShareMedian last round
Seed 3 9% $16.3M
Series A 15 43% $15.4M
Series B 10 29% $32.2M
Series C 6 17% $26.9M
Series D+ 1 3% $28.5M

Table 5. Sofinnova Partners portfolio companies by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Countries

CountriesCompaniesShare
France 12 34%
Switzerland 6 17%
United Kingdom 5 14%
United States 5 14%
Germany 3 9%
Canada 1 3%
The Netherlands 1 3%
Spain 1 3%
Israel 1 3%

Table 6. Sofinnova Partners portfolio companies by headquarters country. Source: FundingWatcher. Data as of 16 November 2026.

Cities

CitiesCompaniesShare
Paris 7 20%
Lyon 2 6%
London 2 6%
Munich 2 6%
Basel 2 6%
Dubendorf 2 6%
Cambridge 1 3%
Cologne 1 3%
Montréal 1 3%
Glasgow 1 3%
Wädenswil 1 3%
Redwood City 1 3%

Table 7. Sofinnova Partners portfolio companies by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.

Rounds by month

Rounds by monthCompaniesShareRaised
November 2026 1 20% $133.0M
August 2026 1 20% $45.9M
February 2026 2 40% $52.9M
December 2025 1 20% $42.3M

Table 8. Sofinnova Partners portfolio companies: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most recent round by year

Most recent round by yearCompaniesShareRaised
2026 4 11% $231.8M
2025 4 11% $204.7M
2024 8 23% $343.9M
2023 5 14% $91.9M
2021 1 3% $35.0M
2020 1 3% $15.4M

Table 9. Sofinnova Partners portfolio companies by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Founding year

Founding yearCompaniesShare
2020 to 2022 9 26%
2015 to 2019 10 29%
2010 to 2014 4 11%
Before 2010 12 34%

Table 10. Sofinnova Partners portfolio companies by founding year. Source: FundingWatcher. Data as of 16 November 2026.

Team size

Team sizeCompaniesShare
1 to 10 7 20%
11 to 50 21 60%
51 to 100 6 17%
101 to 250 1 3%

Table 11. Sofinnova Partners portfolio companies by headcount. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many Sofinnova Partners portfolio companies are on the list?
35, in the file dated 16 November 2026. 5 of them closed their most recent round in the last 12 months.
What does the CSV contain?
One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
How much does the list cost?
$29 one-time for all 35 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV download link, on the page after payment and by mail.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Sofinnova Partners portfolio companies: 35 rows, CSV, $29 one-time.

At once: the CSV download link, on the page after payment and by mail.

Columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.

With founder contacts: $199 one-time. List CSV right after payment; up to 2 verified founder or CEO emails per company compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Portfolio companies by country

Portfolio companies by city

Other venture fund portfolios

Cite: FundingWatcher, 35 startups, 16 November 2026. https://fundingwatcher.com/startups/investor/sofinnova-partners/